Halozyme Therapeutics
HALO
$102.16
Share price
-0.05%
Change (1 day)
61.52%
Change (1 year)
Categories
Market capitalization of Halozyme Therapeutics (HALO)
Market cap: A$12.62 Billion
As of April 2025 Halozyme Therapeutics has a market cap of A$12.62 Billion. This makes Halozyme Therapeutics the world's 1985th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Halozyme Therapeutics from 2004 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$12.62 B | 28.25% |
| 2024 | A$9.84 B | 37.38% |
| 2023 | A$7.16 B | -36.61% |
| 2022 | A$11.30 B | 44.79% |
| 2021 | A$7.80 B | 3.99% |
| 2020 | A$7.50 B | 116.89% |
| 2019 | A$3.46 B | 15.19% |
| 2018 | A$3.00 B | -18.64% |
| 2017 | A$3.69 B | 108.15% |
| 2016 | A$1.77 B | -41.78% |
| 2015 | A$3.04 B | 105.65% |
| 2014 | A$1.48 B | -22.98% |
| 2013 | A$1.92 B | 164.48% |
| 2012 | A$0.72 B | -24.33% |
| 2011 | A$0.96 B | 22.63% |
| 2010 | A$0.78 B | 30.9% |
| 2009 | A$0.59 B | -7.33% |
| 2008 | A$0.64 B | 2.04% |
| 2007 | A$0.63 B | -9.74% |
| 2006 | A$0.70 B | 368.4% |
| 2005 | A$0.14 B | 7.13% |
| 2004 | A$0.13 B |
End of Day market cap according to different sources
On Mar 31st, 2025 the market cap of Halozyme Therapeutics was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | A$2.44 B | -80.64% | 🇺🇸 USA |
 | A$1.187 T | 9,304.34% | 🇺🇸 USA |
 | A$28.10 B | 122.63% | 🇺🇸 USA |
 | A$230.08 B | 1,722.32% | 🇺🇸 USA |
 | A$217.36 B | 1,621.58% | 🇫🇷 France |
 | A$639.83 B | 4,967.62% | 🇺🇸 USA |